Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China · Delayed Price · Currency is CNY 19.09
-0.34 (-1.75%)
Jul 28, 2026, 4:00 PM EDT
SHE:301246 Market Cap
SHE:301246 has a market cap or net worth of 7.62 billion as of July 29, 2026. Its market cap has increased by 24.27% in one year.
Market Cap
7.62B
Enterprise Value
6.63B
Revenue
2.21B
Ranking
n/a
PE Ratio
29.95
Stock Price
19.09
ChartMarket Cap Chart
Since March 20, 2023, SHE:301246's market cap has decreased from 16.78B to 7.62B, a decrease of -54.60%. That is a compound annual growth rate of -20.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 7.58B | -23.64% |
| Dec 31, 2025 | 9.92B | 84.22% |
| Dec 31, 2024 | 5.39B | -48.18% |
| Dec 29, 2023 | 10.39B | -38.07% |
| Mar 20, 2023 | 16.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| North China Pharmaceutical Company.Ltd | 8.18B |
| Zhejiang Hisoar Pharmaceutical | 8.14B |
| Beijing Foyou Pharma CO.,LTD | 8.01B |
| Sunflower Pharmaceutical Group | 7.88B |
| Guilin Sanjin Pharmaceutical | 7.78B |
| Jiuzhitang | 7.78B |
| Frontier Biotechnologies | 7.75B |
| Shanghai Yizhong Pharmaceutical | 7.68B |